SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-21-024376
Filing Date
2021-02-16
Accepted
2021-02-16 17:14:21
Documents
1
Group Members
BIOXCEL LLCKRISHNAN NANDABALANVINMAL MEHTA

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm216888d1_sc13ga.htm SC 13G/A 58059
  Complete submission text file 0001104659-21-024376.txt   59610
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Subject) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90437 | Film No.: 21640804
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2614 BOSTON POST ROAD, SUITE 33B GUILFORD CT 06437
Business Address 2614 BOSTON POST ROAD, SUITE 33B GUILFORD CT 06437 203-643-8060
BioXcel Holdings, Inc. (Filed by) CIK: 0001811154 (see all company filings)

IRS No.: 850849560 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A